54 Results for "

Trt

" in MedChemExpress (MCE) Product Catalog:
Products (54)

54 Results for "Trt" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-W010712
CAS No.: 109425-51-6
Research Areas:  

Others

Fmoc-His(Trt)-OH is a histidine derivative with a trityl (Trt) group protecting the His side chain. Fmoc-His(Trt)-OH also has an Fmoc group protecting the α-NH2 group. Fmoc-His(Trt)-OH can be used in solid-phase peptide synthesis to prevent racemization and byproduct formation. Fmoc-His(Trt)-OH acts as a protected histidine precursor in solid-phase peptide synthesis (SPPS), participating in peptide chain construction through amide bond formation. Fmoc-His(Trt)-OH can be precisely incorporated into the target peptide sequence, ensuring correct peptide chain synthesis and reducing impurity formation. Fmoc-His(Trt)-OH is mainly used in the solid-phase synthesis research of pharmaceutical peptides and bioactive peptides, and is particularly suitable for the preparation of peptide drugs requiring precise control of histidine configuration .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W013081
CAS No.: 132327-80-1
Fmoc-Gln(Trt)-OH is a glutamine derivative containing amine protecting group Fmoc. Fmoc-Gln(Trt)-OH can be used in solid-phase peptide synthesis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-W010788
CAS No.: 32926-43-5
Research Areas:  

Others

Boc-His(Trt)-OH is a histidine derivative .
loading...
    loading...
Cat. No.: HY-W007798
CAS No.: 103213-32-7
Research Areas:  

Others

Fmoc-Cys(Trt)-OH is a cysteine derivative .
loading...
    loading...
Cat. No.: HY-W002327
CAS No.: 132388-59-1
Fmoc-Asn (Trt)-OH is an Fmoc-protected asparagine derivative. Fmoc-Asn (Trt)-OH supports solid-phase peptide synthesis .
loading...
    loading...
Cat. No.: HY-W010714
CAS No.: 200623-62-7
Research Areas:  

Others

Fmoc-D-Gln(Trt)-OH is a glutamine derivative .
loading...
    loading...
Cat. No.: HY-W008876
CAS No.: 201531-88-6
Fmoc-Pen(Trt)-OH is an amino acid derivative with an Fmoc protecting group that can be used to synthesize the inhibitory cystine knot (ICK) peptide ProTx-II .
loading...
    loading...
Cat. No.: HY-W010734
CAS No.: 111061-56-4
Research Areas:  

Others

Fmoc-Ser(Trt)-OH is a serine derivative .
loading...
    loading...
Cat. No.: HY-W013155
CAS No.: 35146-32-8
Research Areas:  

Others

H-His(Trt)-OH is a histidine derivative .
loading...
    loading...
Cat. No.: HY-W010724
CAS No.: 167015-11-4
Research Areas:  

Others

Fmoc-D-Cys(Trt)-OH is a cysteine derivative .
loading...
    loading...
Cat. No.: HY-173374
CAS No.: 3114056-16-2
Target:  

FAP Drug Derivative

Research Areas:  

Cancer

DOTAGA-FAP-2286-ALB is a derivative of Rofapitide tetraxetan (HY-147057). DOTAGA-FAP-2286-ALB is a selective fibroblast activation protein (FAP) inhibitor with an IC50 value of 67.5 nM. DOTAGA-FAP-2286-ALB enhances tumor retention via albumin interaction, prolonging blood circulation and improving radiometal complex stability (e.g., with 111In and 225Ac). DOTAGA-FAP-2286-ALB is promising for research of radionuclide therapy (TRT) of FAP-positive solid tumors .
loading...
    loading...
Cat. No.: HY-W142161
CAS No.: 1217840-61-3
Synonyms: Fmoc-MeHis(Trt)-OH
Research Areas:  

Others

Fmoc-N-Me-His(Trt)-OH (Fmoc-MeHis(Trt)-OH) is an Amino acid derivative containing a carboxyl group. Fmoc-N-Me-His(Trt)-OH can be used for the synthesis of Fmoc-MeHis (Trt)-Leu-OH and N-methyl peptides .
loading...
    loading...
Cat. No.: HY-W011156
CAS No.: 27144-18-9
Research Areas:  

Others

Mpa(Trt) is a 3-mercaptopropionic acid derivative containing a trityl protecting group (Trt) and can be used to synthesize compounds with anti-leukemia activity .
loading...
    loading...
Cat. No.: HY-W048697
CAS No.: 201532-01-6
Research Areas:  

Others

Fmoc-D-Pen(Trt)-OH is an amino acid derivative with an Fmoc protecting group, which can be used to synthesize analogs of cyclic lanthionine enkephalin, a δ-opioid receptor selective ligand .
loading...
    loading...
Cat. No.: HY-129349
CAS No.: 1116085-99-4
Purity:  96.24%
Target:  

ADC Linkers

Research Areas:  

Cancer

Phe-Lys(Trt)-PAB is a cathepsin B substrate, and a cleavable ADC linker. Phe-Lys(Trt)-PAB acts as a lysosomally cleavable substrate for cysteine protease cathepsin B, with cleavage enabling linked anticancer drug release via self-immolative spacer . Phe-Lys(Trt)-PAB can be used for synthesis of ADCs .
loading...
    loading...
Cat. No.: HY-W053550
CAS No.: 25840-82-8
Research Areas:  

Others

H-D-Cys(Trt)-OH is a cysteine derivative .
loading...
    loading...
Cat. No.: HY-129350
CAS No.: 1116086-09-9
Purity:  ≥98.0%
Target:  

ADC Linkers

Research Areas:  

Cancer

Fmoc-Phe-Lys(Trt)-PAB-PNP is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-W108518
CAS No.: 2061897-68-3
Synonyms: Boc-his(Trt)-aib-oh
Target:  

Drug Intermediate

Research Areas:  

Others

(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid (Boc-his(trt)-aib-ohol) is a drug intermediate for synthesis of various active compounds.
loading...
    loading...
Cat. No.: HY-W010719
CAS No.: 180570-71-2
Research Areas:  

Others

N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-(triphenylmethyl)-D-asparagine is an asparagine derivative .
loading...
    loading...
Cat. No.: HY-158118
CAS No.: 2088426-96-2
Purity:  97.19%
Target:  

DNA-PK

Research Areas:  

Cancer

Lys(CO-C3-p-I-Ph)-OMe is a pharmacokinetic modifier (PK modifier) that can improve the PK properties of PSMA ligand molecules (such as Ac-PSMA-trillium). Lys(CO-C3-p-I-Ph)-OMe can increase the residence time of Ac-PSMA-trillium in plasma by increasing its binding capacity to albumin. Lys(CO-C3-p-I-Ph)-OMe also reduces salivary gland absorption of Ac-PSMA-trillium, potentially extending its half-life. Ac-PSMA-trillium is a suitable PSMA-targeting compound that has different biological applications after modification with different radioactive isotopes. If labeled with 111In, it can be used as DOTA chelating agent and imaging agent. Or labeled with 225Ac as a Macropa chelator for targeted radionuclide therapy (TRT) in the study of metastatic castration-resistant prostate cancer (mCRPC) .
loading...
    loading...